Skip to main content
Premium Trial:

Request an Annual Quote

BGI Americas, Advaite Form SARS-CoV-2 Testing Partnership

NEW YORK — BGI Americas said on Tuesday that it has signed an agreement to market its PCR-based SARS-CoV-2 detection kit with Advaite's RapCov COVID-19 immunoassay to hospitals and healthcare facilities.

BGI America's Real-Time Fluorescent RT-PCR Kit is designed to detect SARS-CoV-2 nucleic acid in throat swabs and bronchoalveolar lavage fluid in approximately three hours. It received Emergency Use Authorization from the US Food and Drug Administration in early 2020.

The RapCov Rapid COVID-19 Test is a lateral flow assay designed to detect IgG against SARS-CoV-2 using a fingerstick blood sample in point-of-care settings, providing results in 15 minutes. Malvern, Pennsylvania-based Advaite received FDA EUA for the test in January of this year.

San Jose-based BGI Americas said that offering the assays together will provide customers with both central laboratory and point-of-care CLIA-waived testing options for SARS-CoV-2 testing.

Financial and other terms of the partnership were not disclosed.

BGI Americas also said that it has launched a website through which it solicits licensing, original equipment manufacturer, or distribution agreements with other diagnostic companies for their products.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.